Published in Pharmacol Ther on May 11, 2008
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol (2013) 5.74
Molecular basis for binding and subtype selectivity of 1,4-benzodiazepine antagonist ligands of the cholecystokinin receptor. J Biol Chem (2012) 0.92
Sensitivity of cholecystokinin receptors to membrane cholesterol content. Front Endocrinol (Lausanne) (2012) 0.87
Elucidation of the molecular basis of cholecystokinin Peptide docking to its receptor using site-specific intrinsic photoaffinity labeling and molecular modeling. Biochemistry (2009) 0.84
Membrane cholesterol affects stimulus-activity coupling in type 1, but not type 2, CCK receptors: use of cell lines with elevated cholesterol. Lipids (2013) 0.83
Metabolic Actions of the Type 1 Cholecystokinin Receptor: Its Potential as a Therapeutic Target. Trends Endocrinol Metab (2016) 0.83
Use of multidimensional fluorescence resonance energy transfer to establish the orientation of cholecystokinin docked at the type A cholecystokinin receptor. Biochemistry (2008) 0.80
Development of a highly selective allosteric antagonist radioligand for the type 1 cholecystokinin receptor and elucidation of its molecular basis of binding. Mol Pharmacol (2014) 0.79
Signaling properties and pharmacological analysis of two sulfakinin receptors from the red flour beetle, Tribolium castaneum. PLoS One (2014) 0.78
A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma. Nucleic Acid Ther (2016) 0.78
Photodynamic Physiology-Photonanomanipulations in Cellular Physiology with Protein Photosensitizers. Front Physiol (2017) 0.75
Direct demonstration of unique mode of natural peptide binding to the type 2 cholecystokinin receptor using photoaffinity labeling. Peptides (2013) 0.75
Cholecystokinin receptors in Atlantic salmon: molecular cloning, gene expression, and structural basis. Physiol Rep (2013) 0.75
Development of a time-resolved fluorescence probe for evaluation of competitive binding to the cholecystokinin 2 receptor. Bioorg Med Chem (2015) 0.75
Cholecystokinin-induced satiety, a key gut servomechanism that is affected by the membrane microenvironment of this receptor. Int J Obes Suppl (2016) 0.75
Crystal structure of rhodopsin: A G protein-coupled receptor. Science (2000) 28.60
Effect of cholecystokinin on colonic motility and symptoms in patients with the irritable-bowel syndrome. Lancet (1973) 3.18
GCRDb: a G-protein-coupled receptor database. Receptors Channels (1994) 2.23
Cholecystokinin and gastrin receptors. Physiol Rev (2006) 1.96
The gastrins: their production and biological activities. Annu Rev Physiol (2001) 1.93
Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc Natl Acad Sci U S A (1992) 1.77
Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors. Cancer Res (1997) 1.64
The cell biology of experimental pancreatitis. N Engl J Med (1987) 1.61
Evidence that abnormal myoelectrical activity produces colonic motor dysfunction in the irritable bowel syndrome. Gastroenterology (1977) 1.52
Relationship between native and recombinant cholecystokinin receptors: role of differential glycosylation. Pancreas (1996) 1.46
Abnormal gallbladder motility in irritable bowel syndrome: evidence for target-organ defect. Am J Physiol (1991) 1.41
Dual pathways of internalization of the cholecystokinin receptor. J Cell Biol (1995) 1.33
CCK receptor dysfunction in muscle membranes from human gallbladders with cholesterol stones. Am J Physiol (1999) 1.19
Environment and mobility of a series of fluorescent reporters at the amino terminus of structurally related peptide agonists and antagonists bound to the cholecystokinin receptor. J Biol Chem (2002) 1.15
CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology. Prog Neurobiol (1999) 1.14
Protein folding as posttranslational regulation: evolution of a mechanism for controlled plasma membrane expression of a G protein-coupled receptor. Mol Endocrinol (2006) 1.14
Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study. Am J Gastroenterol (2005) 1.09
Direct G protein activation reverses impaired CCK signaling in human gallbladders with cholesterol stones. Am J Physiol (1995) 1.05
Differential effects of modification of membrane cholesterol and sphingolipids on the conformation, function, and trafficking of the G protein-coupled cholecystokinin receptor. J Biol Chem (2004) 1.04
Probing a model of a GPCR/ligand complex in an explicit membrane environment: the human cholecystokinin-1 receptor. Biophys J (2005) 1.04
Refinement of the conformation of a critical region of charge-charge interaction between cholecystokinin and its receptor. Mol Pharmacol (2002) 1.04
Cholecystokinin antagonists: pharmacological and therapeutic potential. Med Res Rev (2003) 1.03
Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity. 1. Optimization of the agonist "trigger". J Med Chem (1996) 1.03
The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor. Evidence for a crucial role of Met-121 in the activation process. J Biol Chem (2001) 1.03
Met-195 of the cholecystokinin-A receptor interacts with the sulfated tyrosine of cholecystokinin and is crucial for receptor transition to high affinity state. J Biol Chem (1998) 1.00
Direct identification of a second distinct site of contact between cholecystokinin and its receptor. J Biol Chem (1998) 0.99
Agonist-regulated phosphorylation of the pancreatic cholecystokinin receptor. J Biol Chem (1991) 0.98
Molecular complex of cholecystokinin-8 and N-terminus of the cholecystokinin A receptor by NMR spectroscopy. Biochemistry (1999) 0.98
Novel benzodiazepine photoaffinity probe stereoselectively labels a site deep within the membrane-spanning domain of the cholecystokinin receptor. J Med Chem (2006) 0.97
Role of the extracellular domains of the cholecystokinin receptor in agonist binding. Mol Pharmacol (1998) 0.96
Defect of receptor-G protein coupling in human gallbladder with cholesterol stones. Am J Physiol Gastrointest Liver Physiol (2000) 0.96
Fluorescent indicators distributed throughout the pharmacophore of cholecystokinin provide insights into distinct modes of binding and activation of type A and B cholecystokinin receptors. J Biol Chem (2006) 0.94
Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin. Protein Sci (1999) 0.94
The predominant cholecystokinin in human plasma and intestine is cholecystokinin-33. J Clin Endocrinol Metab (2001) 0.93
Arginine 336 and asparagine 333 of the human cholecystokinin-A receptor binding site interact with the penultimate aspartic acid and the C-terminal amide of cholecystokinin. J Biol Chem (1999) 0.92
Distinct molecular mechanisms for agonist peptide binding to types A and B cholecystokinin receptors demonstrated using fluorescence spectroscopy. J Biol Chem (2004) 0.92
Insulation of a G protein-coupled receptor on the plasmalemmal surface of the pancreatic acinar cell. J Cell Biol (1995) 0.92
Mutation of Asn-391 within the conserved NPXXY motif of the cholecystokinin B receptor abolishes Gq protein activation without affecting its association with the receptor. J Biol Chem (2000) 0.92
Nonpeptidic ligands for peptide-activated G protein-coupled receptors. Chem Rev (2007) 0.92
The role of the cholecystokinin-B/gastrin receptor transmembrane domains in determining affinity for subtype-selective ligands. J Biol Chem (1995) 0.92
Altered sensitivity of the gallbladder to cholecystokinin octapeptide in irritable bowel syndrome. Am J Physiol (1987) 0.91
A segment of five amino acids in the second extracellular loop of the cholecystokinin-B receptor is essential for selectivity of the peptide agonist gastrin. J Biol Chem (1996) 0.91
Inositol trisphosphate restores impaired human gallbladder motility associated with cholesterol stones. Gastroenterology (1993) 0.90
Key differences in molecular complexes of the cholecystokinin receptor with structurally related peptide agonist, partial agonist, and antagonist. Mol Pharmacol (2004) 0.90
Disulfide bond structure and accessibility of cysteines in the ectodomain of the cholecystokinin receptor: specific mono-reactive receptor constructs examine charge-sensitivity of loop regions. Receptors Channels (2003) 0.89
Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin. J Biol Chem (1997) 0.89
Multiple kinases phosphorylate the pancreatic cholecystokinin receptor in an agonist-dependent manner. Am J Physiol (1993) 0.88
Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling. Biochemistry (2005) 0.88
Fluorescence resonance energy transfer analysis of the antagonist- and partial agonist-occupied states of the cholecystokinin receptor. J Biol Chem (2005) 0.88
Measurement of intermolecular distances for the natural agonist Peptide docked at the cholecystokinin receptor expressed in situ using fluorescence resonance energy transfer. Mol Pharmacol (2004) 0.87
First intracellular loop of the human cholecystokinin-A receptor is essential for cyclic AMP signaling in transfected HEK-293 cells. J Biol Chem (1997) 0.87
Ligand function at constitutively active receptor mutants is affected by two distinct yet interacting mechanisms. Mol Pharmacol (2004) 0.87
Clinical endocrinology and metabolism. Gastrin. Best Pract Res Clin Endocrinol Metab (2004) 0.87
Specializations of a G-protein-coupled receptor that appear to aid with detection of frequency-modulated signals from its ligand. FASEB J (2006) 0.86
Molecular variants of cholecystokinin after endogenous stimulation in humans: a time study. Am J Physiol (1990) 0.86
Affinity labeling of a novel cholecystokinin-binding protein in rat pancreatic plasmalemma using new short probes for the receptor. J Biol Chem (1987) 0.86
Cholecystokinin and gastrin antagonists. Med Res Rev (1989) 0.85
Single amino acid substitution of serine82 to asparagine in first intracellular loop of human cholecystokinin (CCK)-B receptor confers full cyclic AMP responses to CCK and gastrin. Mol Pharmacol (1999) 0.85
Cholecystokinin. Clin Gastroenterol (1980) 0.85
Agonist-stimulated phosphorylation of the carboxyl-terminal tail of the secretin receptor. Mol Pharmacol (1995) 0.85
Phosphorylation of cholecystokinin receptors expressed on Chinese hamster ovary cells. Similarities and differences relative to native pancreatic acinar cell receptors. J Biol Chem (1996) 0.84
Direct identification of the agonist binding site in the human brain cholecystokininB receptor. Biochemistry (1999) 0.84
Phosphopeptide mapping of cholecystokinin receptors on agonist-stimulated native pancreatic acinar cells. J Biol Chem (1995) 0.84
Molecular basis of agonist binding to the type A cholecystokinin receptor. Pharmacol Toxicol (2002) 0.84
Mechanism of activation of a G protein-coupled receptor, the human cholecystokinin-2 receptor. J Biol Chem (2007) 0.83
Minor modifications of a cholecystokinin-B/gastrin receptor non-peptide antagonist confer a broad spectrum of functional properties. J Biol Chem (1998) 0.83
Evidence for a direct interaction between the penultimate aspartic acid of cholecystokinin and histidine 207, located in the second extracellular loop of the cholecystokinin B receptor. J Biol Chem (1999) 0.83
Palmitoylation of G-protein-coupled receptors: a dynamic modification with functional consequences. Biochem Soc Trans (1995) 0.83
The CCK-B/gastrin receptor. Identification of amino acids that determine nonpeptide antagonist affinity. Ann N Y Acad Sci (1994) 0.83
The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK(1) receptor. Eur J Pharmacol (2000) 0.82
CCK-B/Gastrin receptor transmembrane domain mutations selectively alter synthetic agonist efficacy without affecting the activity of endogenous peptides. Mol Pharmacol (2000) 0.82
Identification of a region of the N-terminal of the human CCKA receptor essential for the high affinity interaction with agonist CCK. Biochem Biophys Res Commun (1995) 0.82
Combination of molecular modeling, site-directed mutagenesis, and SAR studies to delineate the binding site of pyridopyrimidine antagonists on the human CCK1 receptor. J Med Chem (2005) 0.82
His381 of the rat CCKB receptor is essential for CCKB versus CCKA receptor antagonist selectivity. Eur J Pharmacol (1996) 0.81
Roles of cholecystokinin receptor phosphorylation in agonist-stimulated desensitization of pancreatic acinar cells and receptor-bearing Chinese hamster ovary cholecystokinin receptor cells. Mol Pharmacol (1997) 0.81
Stimulation of both CCK-A and CCK-B receptors activates MAP kinases in AR42J and receptor-transfected CHO cells. Digestion (1997) 0.81
Insights into the cholecystokinin 2 receptor binding site and processes of activation. Mol Pharmacol (2006) 0.81
Characterization of cholecystokinin from the human brain. J Neurochem (1984) 0.81
Pharmacology of CCKRs and SAR studies of peptidic analog ligands. Curr Top Med Chem (2007) 0.80
Evidence that interspecies polymorphism in the human and rat cholecystokinin receptor-2 affects structure of the binding site for the endogenous agonist cholecystokinin. J Biol Chem (2005) 0.80
Binding sites and transduction process of the cholecystokininB receptor: involvement of highly conserved aromatic residues of the transmembrane domains evidenced by site-directed mutagenesis. Mol Pharmacol (1998) 0.80
Moleular models for cholecystokinin-A receptor. Pharmacol Toxicol (2002) 0.80
Impaired resensitization and recycling of the cholecystokinin receptor by co-expression of its second intracellular loop. Mol Pharmacol (2000) 0.79
Mutation of Asp100 in the second transmembrane domain of the cholecystokinin B receptor increases antagonist binding and reduces signal transduction. Mol Pharmacol (1995) 0.79
Photoaffinity labeling of the human brain cholecystokinin receptor overexpressed in insect cells. Solubilization, deglycosylation and purification. Eur J Biochem (1996) 0.79
Identification of a domain in the carboxy terminus of CCK receptor that affects its intracellular trafficking. Am J Physiol (1998) 0.79
Strategies for the design of non-peptide CCK2 receptor agonist and antagonist ligand. Curr Top Med Chem (2007) 0.77
Basic amino acids at the C-terminus of the third intracellular loop are required for the activation of phospholipase C by cholecystokinin-B receptors. J Neurochem (1997) 0.77
CCK receptor phosphorylation exposes regulatory domains affecting phosphorylation and receptor trafficking. Am J Physiol Cell Physiol (2000) 0.76
A site-directed mutagenesis study on the conserved alanine residue in the distal third intracellular loops of cholecystokininB and neurotensin receptors. Br J Pharmacol (1997) 0.76
ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nat Genet (2004) 2.85
Light-evoked excitatory and inhibitory synaptic inputs to ON and OFF alpha ganglion cells in the mouse retina. J Neurosci (2003) 2.10
Klf4 organizes long-range chromosomal interactions with the oct4 locus in reprogramming and pluripotency. Cell Stem Cell (2013) 2.04
Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial. Lancet (2013) 1.87
Light-evoked current responses in rod bipolar cells, cone depolarizing bipolar cells and AII amacrine cells in dark-adapted mouse retina. J Physiol (2004) 1.53
The principle of superposition in human prehension. Robotica (2004) 1.52
Finger force vectors in multi-finger prehension. J Biomech (2003) 1.38
Vertically oriented femoral neck fractures: mechanical analysis of four fixation techniques. J Orthop Trauma (2007) 1.32
Relative contributions of rod and cone bipolar cell inputs to AII amacrine cell light responses in the mouse retina. J Physiol (2007) 1.30
Motor control goes beyond physics: differential effects of gravity and inertia on finger forces during manipulation of hand-held objects. Exp Brain Res (2004) 1.22
Molecular approximations between residues 21 and 23 of secretin and its receptor: development of a model for peptide docking with the amino terminus of the secretin receptor. Mol Pharmacol (2007) 1.16
Stratum-by-stratum projection of light response attributes by retinal bipolar cells of Ambystoma. J Physiol (2004) 1.15
Alpha-conotoxins ImI and ImII target distinct regions of the human alpha7 nicotinic acetylcholine receptor and distinguish human nicotinic receptor subtypes. Biochemistry (2004) 1.13
Progress on the research and development of inactivated EV71 whole-virus vaccines. Hum Vaccin Immunother (2013) 1.12
The ubiquitin receptor DA1 interacts with the E3 ubiquitin ligase DA2 to regulate seed and organ size in Arabidopsis. Plant Cell (2013) 1.12
How do tonic glutamatergic synapses evade receptor desensitization? J Physiol (2008) 1.09
Physiological characterization and functional heterogeneity of narrow-field mammalian amacrine cells. J Physiol (2011) 1.09
Direct rod input to cone BCs and direct cone input to rod BCs challenge the traditional view of mammalian BC circuitry. Proc Natl Acad Sci U S A (2009) 1.08
Assessment of heavy metals in sediments from a typical catchment of the Yangtze River, China. Environ Monit Assess (2010) 1.06
Synaptic circuitry mediating light-evoked signals in dark-adapted mouse retina. Vision Res (2004) 1.06
Progress on the research and development of human enterovirus 71 (EV71) vaccines. Front Med (2012) 1.06
Relative contributions of bipolar cell and amacrine cell inputs to light responses of ON, OFF and ON-OFF retinal ganglion cells. Vision Res (2002) 1.03
Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice. PLoS One (2012) 1.02
Segregation and integration of visual channels: layer-by-layer computation of ON-OFF signals by amacrine cell dendrites. J Neurosci (2002) 1.01
Curariform antagonists bind in different orientations to the nicotinic receptor ligand binding domain. J Biol Chem (2003) 1.01
Changes of calf muscle-tendon biomechanical properties induced by passive-stretching and active-movement training in children with cerebral palsy. J Appl Physiol (1985) (2011) 1.00
The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children. PLoS One (2013) 1.00
Prehension stability: experiments with expanding and contracting handle. J Neurophysiol (2005) 0.98
Insights into the structural basis of endogenous agonist activation of family B G protein-coupled receptors. Mol Endocrinol (2008) 0.98
Light responses and morphology of bNOS-immunoreactive neurons in the mouse retina. J Comp Neurol (2010) 0.95
Cross-talk between ON and OFF channels in the salamander retina: indirect bipolar cell inputs to ON-OFF ganglion cells. Vision Res (2006) 0.94
Synthesis and in vitro characterization of radioiodinatable benzodiazepines selective for type 1 and type 2 cholecystokinin receptors. J Med Chem (2009) 0.93
Rod, M-cone and M/S-cone inputs to hyperpolarizing bipolar cells in the mouse retina. J Physiol (2012) 0.92
Proteomics shows Hsp70 does not bind peptide sequences indiscriminately in vivo. Exp Cell Res (2004) 0.91
Rotational equilibrium during multi-digit pressing and prehension. Motor Control (2004) 0.89
Reactogenicity and immunogenicity of an enterovirus 71 vaccine in Chinese healthy children and infants. Pediatr Infect Dis J (2012) 0.89
Regulation of induced pluripotent stem (iPS) cell induction by Wnt/β-catenin signaling. J Biol Chem (2014) 0.88
Biological implications and regulatory mechanisms of long-range chromosomal interactions. J Biol Chem (2013) 0.88
Immunogenicity, safety, and lot consistency of a novel inactivated enterovirus 71 vaccine in Chinese children aged 6 to 59 months. Clin Vaccine Immunol (2013) 0.87
Functional and structural diversification of the Anguimorpha lizard venom system. Mol Cell Proteomics (2010) 0.87
Paclitaxel/sirolimus combination coated drug-eluting stent: in vitro and in vivo drug release studies. J Pharm Biomed Anal (2010) 0.86
Non-linear, high-gain and sustained-to-transient signal transmission from rods to amacrine cells in dark-adapted retina of Ambystoma. J Physiol (2002) 0.85
Occurrence and possible sources of polychlorinated biphenyls in surface sediments from the Wuhan reach of the Yangtze River, China. Chemosphere (2008) 0.85
Joining and interconnect formation of nanowires and carbon nanotubes for nanoelectronics and nanosystems. Small (2009) 0.84
Extra-articular distal tibia fractures: a mechanical evaluation of 4 different treatment methods. J Orthop Trauma (2010) 0.84
Development and evaluation of a pseudovirus-luciferase assay for rapid and quantitative detection of neutralizing antibodies against enterovirus 71. PLoS One (2013) 0.84
Molecular cloning, characterization and expression of cDNA encoding translationally controlled tumor protein (TCTP) from Jatropha curcas L. Mol Biol Rep (2010) 0.82
G protein-coupled receptor structures, molecular associations, and modes of regulation. Ann N Y Acad Sci (2008) 0.82
Characterization of displaced bipolar cells in the tiger salamander retina. Vision Res (2005) 0.82
Use of multidimensional fluorescence resonance energy transfer to establish the orientation of cholecystokinin docked at the type A cholecystokinin receptor. Biochemistry (2008) 0.80
Genomic and transcriptome analysis revealing an oncogenic functional module in meningiomas. Neurosurg Focus (2013) 0.80
An Sb-doped p-type ZnO nanowire based random laser diode. Nanotechnology (2016) 0.79
Structural basis for epibatidine selectivity at desensitized nicotinic receptors. Mol Pharmacol (2004) 0.79
On-line sample preconcentration technique based on a dynamic pH junction in CE-amperometric detection for the analysis of biogenic amines in urine. Electrophoresis (2013) 0.79
Synthesis of surface roughed Pt nanowires and their application as electrochemical sensors for hydrogen peroxide detection. J Nanosci Nanotechnol (2014) 0.78
Changes of Achilles tendon properties via 12-week PNF based robotic rehabilitation of ankle joints with spasticity and/or contracture. Conf Proc IEEE Eng Med Biol Soc (2014) 0.77
Ionotropic glutamate receptors mediate OFF responses in light-adapted ON bipolar cells. Vision Res (2012) 0.77
[Treatment of obstructive sleep apnea-hypopnea syndrome for children refractory asthma]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2014) 0.76
Type I interferon related genes are common genes on the early stage after vaccination by meta-analysis of microarray data. Hum Vaccin Immunother (2015) 0.75
Recent structural and mechanistic insights into endplate acetylcholine receptors. Ann N Y Acad Sci (2008) 0.75
Pathway-Wide Association Study Implicates Multiple Sterol Transport and Metabolism Genes in HDL Cholesterol Regulation. Front Genet (2011) 0.75
Toward atomic-scale understanding of ligand recognition in the muscle nicotinic receptor. Curr Med Chem (2004) 0.75
1H NMR investigations of inclusion complexes between beta-cyclodextrin and 1-hexadecanol. Curr Drug Discov Technol (2007) 0.75
Preparation of ceramic-corrosion-cell fillers and application for cyclohexanone industry wastewater treatment in electrobath reactor. J Hazard Mater (2011) 0.75
ACT-6, a novel plasmid-encoded class C β-lactamase in a Klebsiella pneumoniae isolate from China. J Antibiot (Tokyo) (2011) 0.75
Wavefront distortion optimized with volume Bragg gratings in photothermorefractive glass. Opt Lett (2016) 0.75
Informed development of drugs acting at family B G protein-coupled receptors. Ann N Y Acad Sci (2008) 0.75
[Determination of acidity in oranges based on emphatic orthogonal signal correction and principal component orthogonal signal correction]. Guang Pu Xue Yu Guang Pu Fen Xi (2012) 0.75
[Analysis of the causes of pediatric rhino-source diseases]. Zhonghua Er Ke Za Zhi (2009) 0.75
Monolithic beam splitter in silicon-on-insulator. Opt Express (2004) 0.75
A photogrammetry-based system for 3D surface reconstruction of prosthetics and orthotics. Conf Proc IEEE Eng Med Biol Soc (2011) 0.75
2 × 64 Gb/s PAM-4 transmission over 70 km SSMF using O-band 18G-class directly modulated lasers (DMLs). Opt Express (2017) 0.75
Polychlorinated biphenyls in urban lake sediments from wuhan, central China: occurrence, composition, and sedimentary record. J Environ Qual (2009) 0.75
Bidirectional nanoprinting based on bilayer metasurfaces. Opt Express (2022) 0.75
Fabrication of lateral electrodes on semiconductor nanowires through structurally matched insulation for functional optoelectronics. Nanotechnology (2012) 0.75
Enzyme-Driven Membrane-Targeted Chimeric Peptide for Enhanced Tumor Photodynamic-Immunotherapy. ACS Nano (2019) 0.75
In situ visualization of metallurgical reactions in nanoscale Cu/Sn diffusion couples. Nanoscale (2015) 0.75
Scalable alignment of CdS nanowires based on efficient roll-on transfer technique. J Nanosci Nanotechnol (2013) 0.75
[Analysis of intractable cough in 128 children]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2010) 0.75
Optimization of spatial filter with volume Bragg gratings in photo-thermo-refractive glass. Opt Lett (2014) 0.75